Asthma versus chronic obstructive pulmonary disease - Exploring why 'reversibility versus irreversibility' is no longer an appropriate approach

Clinical and Experimental Allergy

Volumn 29, Issue 6, 1999, Pages 739-743

  Dow, L ^a,b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AIRWAY OBSTRUCTION; ASTHMA; ATOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIFFERENTIAL DIAGNOSIS; FAMILY HISTORY; HUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING; SYNDROME DELINEATION;

AIRWAY OBSTRUCTION; ASTHMA; HUMANS; LUNG DISEASES, OBSTRUCTIVE; TERMINOLOGY;

EID: 0033026761     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1999.00589.x     Document Type: Review

References (32)

1. 1 Dow L, Coggon D, Osmond C, Holgate ST. A population survey of respiratory symptoms in the elderly. Eur Respir J 1991; 4:267-72.
2. 2 Dodge R, Cline MG, Burrows B. Comparisons of asthma, emphysema, and chronic bronchitis diagnoses in a general population sample. Am Rev Respir Dis 1986; 133:981-6.
3. 3 Burrows B, Bloom JW, Traver GA, Cline MG. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. NEJM 1987; 317:1309-14.
4. 4 Gibson PG, Hargreave FE, Girgis-Gabardo A, Morris M, Denburg JA, Dolovich J. Chronic cough with eosinophilic bronchitis: examination for variable airflow obstruction and response to corticosteroid. Clin Exp Allergy 1995; 25:127-32.
5. 5 Gibson PG, Zlatic K, Scott J, Woolley K, Saltos N. Chronic cough resembles asthma with IL-5 and granulocyte-macrophage colony-stimulating factor gene expression in bronchoalveolar cells. J Allergy Clin Immunol 1998; 101:320-6.
6. 6 Bodner CH, Ross S, Little J, Douglas JG, Legge JS, Friend JA, Godden DJ. Risk factors for adult onset wheeze: a case control study. Am J Respir Crit Care Med 1998; 157:35-42.
7. 7 Braman SS, Kaemmerlen JT, Davis SM. Asthma in the elderly. Am Rev Respir Dis 1991; 143:336-40.
8. 8 Brown PJ, Greville HW, Finucane KE. Asthma and irreversible airflow obstruction. Thorax 1984; 39:131-6.
9. 9 Backman KS, Greenberger PA, Patterson R. Airways obstruction in patients with long-term asthma consistent with 'Irreversible asthma'. Chest 1997; 112:1234-40.
10. 10 Kondoh Y, Taniguchi H, Yokoyama S, Taki F, Takagi K, Satake T. Emphysematous change in chronic asthma in relation to cigarette smoking. Chest 1990; 97:845-9.
11. 11 Peat JK, Woolcock AJ, Cullen K. Rate of decline in lung function in subjects with asthma. Eur Resp J 1987; 70:171-9.
12. 12 Ulrik CS, Backer V, Dirksen A. A 10 year follow up of 180 adults with bronchial asthma: factors important for the decline in lung function. Thorax 1992; 47:14-8.
13. 13 Ulrik CS, Lange P. Decline of lung function in adults with bronchial asthma. Am J Respir Crit Care Med 1994; 150:629-34.
14. 14 Haahtela T, Jarvinen M, Kava T et al. Comparison of a beta-2-agonist, terbutaline with an inhaled corticosteroid, budesonide, in newly detected asthma. NEJM 1991; 325:388-92.
15. 15 Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994; 88:373-81.
16. 16 Burrows B, Lebowitz MD, Barbee RA, Cline MG. Findings before diagnoses of asthma among the elderly in a longitudinal study of a general population. J Allergy Clin Immunol 1991; 88:870-7.
17. 17 Parameswaran K, Hildreth AJ, Chadha D, Keaney NP. Asthma in the elderly: underperceived, underdiagnosed and undertreated; a community survey. Resp Med 1998; 92:573-7.
18. 18 Corris PA, Gibson GJ. Asthma presenting as Cor pulmonale. BMJ 1984; 288:289-390.
19. 19 Dunn AM, Wilson RSE, Hill LF. Asthma presenting as Cor pulmonale. Postgrad Med J 1983; 59:777-8.
20. 20 Wilson GE, Evans CC. Cor pulmonale due to untreated asthma in a young woman with co-existent anorexia nervosa. Respiratory Medicine 1995; 89:631-3.
21. 21 Saetta M, Di Stefano A, Maestrelli P et al. Airway eosinophilia and expression of interleukin-5 protein in asthma and in exacerbations of chronic bronchitis. Clin Exp Allergy 1996; 26:766-74.
22. 22 Pavord ID, Pizzichini MMM, Pizzichini E, Hargreave FE. The use of induced sputum to investigate airway inflammation. Thorax 1997; 52:498-501.
23. 23 Callahan CM, Dittus RS, Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease. Ann Intern Med 1991; 114:216-23.
24. 24 Brand PLP, Quanjer PH, Postma DS et al. Interpretation of the bronchodilator response in patients with obstructive airways disease. Thorax 1992; 47:429-36.
25. 25 Thompson AB, Daughton D, Robbins RA, Ghafouri MA, Ochlerking M, Rennard SI. Intraluminal airway inflammation in chronic bronchitis characterization and correlation with clinical parameters. Am Rev Respir Dis 1989; 140:1527-37.
26. 26 Confalonieri M, Mainardi E, Porta RD et al. Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease. Thorax 1998; 53:583-5.
27. 27 Paggiaro PL, Dahle R, Bakran I, Frith L, Holllingworth K, Efthimiou J. Multi-centre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. Lancet 1998; 351:773-80.
28. 28 Jackevicius CA, Chapman KR. Prevalence of inhaled corticosteroid use among patients with chronic obstructive pulmonary disease: a survey. Ann Pharmacotherapy 1997; 31:160-4.
29. 29 Chanez P, Vignola AM, O'Shaugnessy T et al. Corticosteroid reversibility in COPD is related to features of asthma. Am J Crit Care Med 1997; 155:1529-34.
30. 30 Nagai A, Thurlbeck WM, Konno K. Responsiveness and variability of airflow obstruction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 151:635-9.
31. 31 Tiddens HAW, Pare PD, Hogg JC, Hop WCJ, Lambert R, De Jongste JC. Cartilaginous airway dimensions and airflow obstruction in human lungs. Am J Respir Crit Care Med 1995; 152:260-6.
32. 32 Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airways obstruction in chronic obstructive pulmonary disease. NEJM 1968; 129:989-94.